Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”
ACS Nano · 2024
DOI: 10.1021/acsnano.4c08574 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Panpan Xue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Strait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Key Laboratory of Flexible Electronics, Fujian Normal University and Str…. Hauptthemen laut MEDLINE: Silicon Dioxide, Ferroptosis, Breast Neoplasms, Iron. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Projects of Fujian Province, Fujian Normal University.
Abstract (Originalsprache)
The activation of cellular ferroptosis is promising in tumor therapy. However, ferroptosis is parallelly inhibited by antiferroptotic substances, including glutathione peroxidase 4 (GPX4), dihydroorotate dehydrogenase (DHODH), and ferroptosis suppressor protein 1 (FSP1). Thus, it is highly desirable, yet challenging, to simultaneously suppress these three antiferroptotic substances for activating ferroptosis. Here, we rationally designed a hollow iron-doped SiO2-based nanozyme (FeSHS) loaded with brequinar (BQR) and lificiguat (YC-1), named FeSHS/BQR/YC-1-PEG, for tumor ferroptosis activation. FeSHS were developed through the continuous etching of SiO2 nanoparticles by iron ions, which exhibit pH/glutathione-responsive biodegradability, along with mimicking the activities of peroxidase, glutathione oxidase, and NAD(P)H oxidase. Specifically, glutathione depletion and NAD(P)H oxidation by FeSHS will suppress the expression of GPX4 and inhibit FSP1 by disrupting the NAD(P)H/FSP1/ubiquinone axis. In addition, the released BQR can suppress the expression of DHODH. Meanwhile, YC-1 is able to increase the cellular polyunsaturated fatty acids (PUFAs) by destroying the HIF-1α/lipid droplet axis. The elevation of levels of iron and PUFAs while simultaneously disrupting the GPX4/DHODH/FSP1 inhibitory pathways by our designed nanoplatform displayed high therapeutic efficacy both in vitro and in vivo. This work elucidates rationally designing smart nanoplatforms for ferroptosis activation and future tumor treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Strait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Key Laboratory of Flexible Electronics, Fujian Normal University and Strait Laboratory of Flexible Electronics (SLoFE), Fuzhou 350117, China.
- Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, 1 Keji Road, Fuzhou 350117, PR Chi…
ORCID-Profile: Shuangqian Yan
Förderung
- National Natural Science Foundation of China
- Science and Technology Projects of Fujian Province
- Fujian Normal University
Zitieren
APA
Xue, P., Zhuang, H., Shao, S., Bai, T., Zeng, X., & Yan, S. (2024). Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”. ACS Nano. https://doi.org/10.1021/acsnano.4c08574
Vancouver
Xue P, Zhuang H, Shao S, Bai T, Zeng X, Yan S. Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”. ACS Nano. 2024. doi:10.1021/acsnano.4c08574
BibTeX
@article{Xue2024,
author = {Xue, Panpan and Zhuang, Huilan and Shao, Sijie and Bai, Tingjie and Zeng, Xuemei and Yan, Shuangqian},
title = {Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c08574}
}
EUVIMED